Abstract
As one of the most densely populated countries in the world, Bangladesh have been trying to contain the impact of a pandemic like COVID-19 since March, 2020. Although government announced an array of restricted measures to slow down the diffusion in the beginning of the pandemic, the lockdown has been lifted gradually by reopening all the industries, markets and offices with a notable exception of educational institutes. As the physical geography of Bangladesh is highly variable across the largest delta, the population of different region and their life style also differ. Thus, to get the real scenario of the current pandemic across Bangladesh, it is essential to analyze the transmission dynamics over the individual districts. In this article, we propose to integrate the Unscented Kalman Filter (UKF) with classic SIRD model to explain the epidemic evolution of individual districts in the country. We show that UKF-SIRD model results in a robust prediction of the transmission dynamics for 1-4 months. Then we apply the robust UKF-SIRD model over different regions in Bangladesh to estimates the course of the epidemic. Our analysis demonstrate that in addition to the densely populated areas, industrial areas and popular tourist spots are in the risk of higher COVID-19 transmission. In the light of these outcomes, we provide a set of suggestions to contain the pandemic in Bangladesh. All the data and relevant codebase is available at https://mjonyh.github.io.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
N/A
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All the data and relevant codebase is available at https://mjonyh.github.io.
